PARIS, France—The latest SORT-OUT trial to pit two commercially available drug-eluting stents against one another in routine care suggests that the cobalt-chromium, everolimus-eluting Synergy stent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results